Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states

C. R. Smith, J. Butler, I. Hashim, M. R. Norman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Serum prolactin concentrations were measured using a sensitive bioassay (Nb2 assay) and by radioimmunoassay in 11 patients with prolactin-secreting pituitary tumours (median serum immunoreactive prolactin 5150 mU/L), and in 58 normal control subjects (median prolactin 190 mU/L). The mean ratio of serum prolactin bioactivity to immunoactivity was significantly lower in patients with prolactinomas than in normoprolactinaemic controls. Ten lactating women in the early post-partum period (median prolactin 3800 mU/L), studied as a model of physiological hyperprolactinaemia, also had reduced bioactivity to immunoactivity ratios. Overall, there was a significant negative correlation between bioactivity:immunoactivity ratio and serum immunoactive prolactin. The change in relative bioactivity of prolactin in serum samples from patients with prolactinomas and in women with physiological hyperprolactinaemia may reflect changes in the molecular heterogeneity of the hormone. Such changes may affect activity in both bioassays and radioimmunoassays.

Original languageEnglish (US)
Pages (from-to)3-8
Number of pages6
JournalAnnals of Clinical Biochemistry
Volume27
Issue number1
StatePublished - 1990

Fingerprint

Bioactivity
Prolactin
Serum
Prolactinoma
Hyperprolactinemia
Bioassay
Biological Assay
Radioimmunoassay
Pituitary Neoplasms
Tumors
Assays
Hormones

Keywords

  • bioassay
  • Prolactinoma

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states. / Smith, C. R.; Butler, J.; Hashim, I.; Norman, M. R.

In: Annals of Clinical Biochemistry, Vol. 27, No. 1, 1990, p. 3-8.

Research output: Contribution to journalArticle

Smith, C. R. ; Butler, J. ; Hashim, I. ; Norman, M. R. / Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states. In: Annals of Clinical Biochemistry. 1990 ; Vol. 27, No. 1. pp. 3-8.
@article{d8e3c0a6bdfa4c5aa8f582895f949305,
title = "Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states",
abstract = "Serum prolactin concentrations were measured using a sensitive bioassay (Nb2 assay) and by radioimmunoassay in 11 patients with prolactin-secreting pituitary tumours (median serum immunoreactive prolactin 5150 mU/L), and in 58 normal control subjects (median prolactin 190 mU/L). The mean ratio of serum prolactin bioactivity to immunoactivity was significantly lower in patients with prolactinomas than in normoprolactinaemic controls. Ten lactating women in the early post-partum period (median prolactin 3800 mU/L), studied as a model of physiological hyperprolactinaemia, also had reduced bioactivity to immunoactivity ratios. Overall, there was a significant negative correlation between bioactivity:immunoactivity ratio and serum immunoactive prolactin. The change in relative bioactivity of prolactin in serum samples from patients with prolactinomas and in women with physiological hyperprolactinaemia may reflect changes in the molecular heterogeneity of the hormone. Such changes may affect activity in both bioassays and radioimmunoassays.",
keywords = "bioassay, Prolactinoma",
author = "Smith, {C. R.} and J. Butler and I. Hashim and Norman, {M. R.}",
year = "1990",
language = "English (US)",
volume = "27",
pages = "3--8",
journal = "Annals of Clinical Biochemistry",
issn = "0004-5632",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states

AU - Smith, C. R.

AU - Butler, J.

AU - Hashim, I.

AU - Norman, M. R.

PY - 1990

Y1 - 1990

N2 - Serum prolactin concentrations were measured using a sensitive bioassay (Nb2 assay) and by radioimmunoassay in 11 patients with prolactin-secreting pituitary tumours (median serum immunoreactive prolactin 5150 mU/L), and in 58 normal control subjects (median prolactin 190 mU/L). The mean ratio of serum prolactin bioactivity to immunoactivity was significantly lower in patients with prolactinomas than in normoprolactinaemic controls. Ten lactating women in the early post-partum period (median prolactin 3800 mU/L), studied as a model of physiological hyperprolactinaemia, also had reduced bioactivity to immunoactivity ratios. Overall, there was a significant negative correlation between bioactivity:immunoactivity ratio and serum immunoactive prolactin. The change in relative bioactivity of prolactin in serum samples from patients with prolactinomas and in women with physiological hyperprolactinaemia may reflect changes in the molecular heterogeneity of the hormone. Such changes may affect activity in both bioassays and radioimmunoassays.

AB - Serum prolactin concentrations were measured using a sensitive bioassay (Nb2 assay) and by radioimmunoassay in 11 patients with prolactin-secreting pituitary tumours (median serum immunoreactive prolactin 5150 mU/L), and in 58 normal control subjects (median prolactin 190 mU/L). The mean ratio of serum prolactin bioactivity to immunoactivity was significantly lower in patients with prolactinomas than in normoprolactinaemic controls. Ten lactating women in the early post-partum period (median prolactin 3800 mU/L), studied as a model of physiological hyperprolactinaemia, also had reduced bioactivity to immunoactivity ratios. Overall, there was a significant negative correlation between bioactivity:immunoactivity ratio and serum immunoactive prolactin. The change in relative bioactivity of prolactin in serum samples from patients with prolactinomas and in women with physiological hyperprolactinaemia may reflect changes in the molecular heterogeneity of the hormone. Such changes may affect activity in both bioassays and radioimmunoassays.

KW - bioassay

KW - Prolactinoma

UR - http://www.scopus.com/inward/record.url?scp=0025021474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025021474&partnerID=8YFLogxK

M3 - Article

C2 - 2310154

AN - SCOPUS:0025021474

VL - 27

SP - 3

EP - 8

JO - Annals of Clinical Biochemistry

JF - Annals of Clinical Biochemistry

SN - 0004-5632

IS - 1

ER -